Financhill
Sell
43

WGS Quote, Financials, Valuation and Earnings

Last price:
$136.21
Seasonality move :
46.27%
Day range:
$133.00 - $136.64
52-week range:
$55.17 - $170.87
Dividend yield:
0%
P/E ratio:
2,256.88x
P/S ratio:
9.70x
P/B ratio:
13.46x
Volume:
187.5K
Avg. volume:
447K
1-year change:
75.83%
Market cap:
$3.9B
Revenue:
$305.5M
EPS (TTM):
$0.06

Earnings Data

Next earnings date for WGS
Feb 17
2026
Most recent earnings per share
-$0.27
Missed by $0.69
(Oct 28/2025)
Consensus Estimate
$0.42
(Oct 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

WGS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/17/2026 Q4 $120.5M -- -- $0.11 --
10/28/2025 Q3 $104.7M $116.7M -$0.27 $0.42 -$0.69
07/29/2025 Q2 $85.6M $102.7M $0.36 $0.11 $0.26
04/30/2025 Q1 $79.8M $87.1M -$0.23 $0.09 -$0.32
02/18/2025 Q4 $82.2M $95.6M $0.19 $0.10 $0.09
10/29/2024 Q3 $65M $76.9M -$0.31 -$0.22 -$0.09
07/30/2024 Q2 $59.3M $70.5M -$1.10 -$0.30 -$0.80
04/29/2024 Q1 $49.5M $62.4M -$0.78 -$0.67 -$0.11
02/20/2024 Q4 $57.6M $57.4M -$0.99 -$0.65 -$0.34
10/30/2023 Q3 -- $53.3M -$1.64 -- --
08/08/2023 Q2 -- $48.7M -$1.84 -- --
05/09/2023 Q1 -- $43.1M -$3.04 -- --
03/14/2023 Q4 -- $61.4M -$26.23 -- --
11/14/2022 Q3 -- $83.2M -$6.72 -- --
06/30/2022 Q2 -- $36.2M -$8.38 -- --
03/31/2022 Q1 -- $53.9M -$10.38 -- --
12/31/2021 Q4 -- $57.8M -$5.49 -- --
09/30/2021 Q3 -- $43.2M $5.14 -- --
06/30/2021 Q2 -- $47M -$1,383.91 -- --
03/31/2021 Q1 -- $64.2M -$11,511.15 -- --
12/31/2020 Q4 -- $64M -$207,470.31 -- --
09/30/2020 Q3 -- $38.6M -$33.76 -- --

GeneDx Holdings Corp. Earnings Questions

  • How Much did GeneDx Holdings Corp. Generate in Revenue Last Quarter?

    GeneDx Holdings Corp. reported $116.7M worth of top line sales in its most recent quarter.

  • Did GeneDx Holdings Corp. Beat Earnings Last Quarter?

    GeneDx Holdings Corp. announced earnings per share of -$0.27 which represents a miss of analyst forecast a $0.42 per share.

  • Is GeneDx Holdings Corp. Profitable?

    GeneDx Holdings Corp. reported $79.4M that represents $2.76 per share over the last quarter.

  • What is the Analyst Consensus for GeneDx Holdings Corp. EPS Next Year?

    GeneDx Holdings Corp.'s earnings are forecast to decrease from -$1.94 per share to -$0.35 per share next year representing a decrease of -95.16%.

  • When is GeneDx Holdings Corp.'s Earnings Date?

    GeneDx Holdings Corp.'s next earnings date is February 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock